Is Broadcom Stock a Millionaire Maker?
Broadcom (Nasdaq: AVGO) stock has gone up more than 64%…
Buy
54
IR Quote, Financials, Valuation and Earnings
Last price:
$75.91
Seasonality move
:
3.05%
Day range:
$75.99 - $77.98
52-week range:
$65.61 - $106.03
Dividend yield:
0.1%
P/E ratio:
38.09x
P/S ratio:
4.30x
P/B ratio:
2.96x
Volume:
3.7M
Avg. volume:
3.6M
1-year change:
-11.27%
Market cap:
$31B
Revenue:
$7.2B
EPS (TTM):
$2.02
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $4B | $5.2B | $5.9B | $6.9B | $7.2B | |
| Revenue Growth (YoY) | 96.94% | 29.68% | 14.83% | 16.22% | 5.22% | |
| Cost of Revenues | $2.6B | $3.2B | $3.6B | $4B | $4.1B | |
| Gross Profit | $1.4B | $2B | $2.3B | $2.9B | $3.2B | |
| Gross Profit Margin | 35.36% | 38.59% | 39.31% | 41.92% | 43.82% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $789.3M | $1B | $1.1B | $1.3B | $1.3B | |
| Other Inc / (Exp) | -$208.7M | -$21.7M | -$34M | -$53.7M | -$108.3M | |
| Operating Expenses | $1.1B | $1.4B | $1.4B | $1.6B | $1.7B | |
| Operating Income | $274.4M | $622.4M | $879.4M | $1.2B | $1.5B | |
| Net Interest Expenses | $111.1M | $87.7M | $103.2M | $156.7M | $213.2M | |
| EBT. Incl. Unusual Items | -$45.4M | $513M | $742.2M | $1B | $1.1B | |
| Earnings of Discontinued Ops. | $24.4M | $41.6M | $15.2M | -- | -- | |
| Income Tax Expense | $11.4M | -$21.8M | $149.6M | $240M | $262.5M | |
| Net Income to Company | -$56.8M | $523.4M | $593.3M | $785.1M | $846.3M | |
| Minority Interest in Earnings | -$900K | -$2.5M | -$3.8M | -$6.4M | -$7.7M | |
| Net Income to Common Excl Extra Items | -$33.3M | $562.5M | $604.7M | $778.7M | $838.6M | |
| Basic EPS (Cont. Ops) | -$0.09 | $1.36 | $1.49 | $1.92 | $2.08 | |
| Diluted EPS (Cont. Ops) | -$0.09 | $1.34 | $1.47 | $1.90 | $2.06 | |
| Weighted Average Basic Share | $382.8M | $414.8M | $405.3M | $404.8M | $403.4M | |
| Weighted Average Diluted Share | $382.8M | $421.2M | $410.2M | $409M | $407.2M | |
| EBITDA | $478.2M | $1B | $1.3B | $1.6B | $1.8B | |
| EBIT | $65.7M | $600.7M | $845.4M | $1.2B | $1.3B | |
| Revenue (Reported) | $4B | $5.2B | $5.9B | $6.9B | $7.2B | |
| Operating Income (Reported) | $274.4M | $622.4M | $879.4M | $1.2B | $1.5B | |
| Operating Income (Adjusted) | $65.7M | $600.7M | $845.4M | $1.2B | $1.3B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.1B | $1.3B | $1.6B | $1.7B | $1.7B | |
| Revenue Growth (YoY) | 60.55% | 18.37% | 21.86% | 2.5% | 2.8% | |
| Cost of Revenues | $677.4M | $810.9M | $965.1M | $923.8M | $951.3M | |
| Gross Profit | $452.1M | $526.1M | $664.2M | $746.3M | $765.5M | |
| Gross Profit Margin | 40.03% | 39.35% | 40.77% | 44.69% | 44.59% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $252.3M | $265.5M | $311.1M | $336.3M | $350M | |
| Other Inc / (Exp) | $8.2M | -$11.6M | -$9.5M | -$11.1M | -$10.1M | |
| Operating Expenses | $336.5M | $352.9M | $404.8M | $428.8M | $441.1M | |
| Operating Income | $115.6M | $173.2M | $259.4M | $317.5M | $324.4M | |
| Net Interest Expenses | $23.1M | $19M | $38.9M | $36.8M | $61.2M | |
| EBT. Incl. Unusual Items | $100.7M | $142.6M | $211M | $269.6M | $253.1M | |
| Earnings of Discontinued Ops. | -$180.2M | -$1.4M | -- | -- | -- | |
| Income Tax Expense | $10.6M | $32.4M | $48.1M | $54.4M | $58.5M | |
| Net Income to Company | $90.1M | $105.9M | $163.2M | $204.5M | $188.4M | |
| Minority Interest in Earnings | -$300K | -$800K | -$2.1M | -$2.3M | -$1.9M | |
| Net Income to Common Excl Extra Items | -$90.4M | $103.7M | $161.1M | $202.2M | $186.5M | |
| Basic EPS (Cont. Ops) | -$0.22 | $0.25 | $0.40 | $0.50 | $0.46 | |
| Diluted EPS (Cont. Ops) | -$0.22 | $0.25 | $0.39 | $0.50 | $0.46 | |
| Weighted Average Basic Share | $419.2M | $407.6M | $405M | $403.5M | $403.1M | |
| Weighted Average Diluted Share | $425.9M | $413.1M | $409.2M | $407.9M | $406.4M | |
| EBITDA | $229.3M | $270.1M | $363.9M | $423.6M | $434.3M | |
| EBIT | $123.8M | $161.6M | $249.9M | $306.4M | $314.3M | |
| Revenue (Reported) | $1.1B | $1.3B | $1.6B | $1.7B | $1.7B | |
| Operating Income (Reported) | $115.6M | $173.2M | $259.4M | $317.5M | $324.4M | |
| Operating Income (Adjusted) | $123.8M | $161.6M | $249.9M | $306.4M | $314.3M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $4.5B | $5.4B | $6.2B | $6.9B | $7.3B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $2.8B | $3.3B | $3.7B | $4B | $4.1B | |
| Gross Profit | $1.7B | $2.1B | $2.5B | $3B | $3.2B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $902.2M | $1B | $1.1B | $1.3B | $1.4B | |
| Other Inc / (Exp) | -$103.7M | -$42.8M | -$31.9M | -$55.3M | -$107.3M | |
| Operating Expenses | $1.3B | $1.4B | $1.5B | $1.7B | $1.7B | |
| Operating Income | $374.3M | $681.3M | $965.6M | $1.3B | $1.5B | |
| Net Interest Expenses | $107.1M | $83.6M | $123.1M | $154.6M | $237.6M | |
| EBT. Incl. Unusual Items | $163.5M | $554.9M | $810.6M | $1.1B | $1.1B | |
| Earnings of Discontinued Ops. | -$160.2M | $220.4M | $16.6M | -- | -- | |
| Income Tax Expense | $88.9M | -- | $165.3M | $246.3M | $266.6M | |
| Net Income to Company | $71.3M | $539.2M | $650.6M | $826.4M | $830.2M | |
| Minority Interest in Earnings | -$1.3M | -$3M | -$5.1M | -$6.6M | -$7.3M | |
| Net Income to Common Excl Extra Items | -$86.9M | $756.6M | $662.1M | $819.8M | $822.9M | |
| Basic EPS (Cont. Ops) | -$0.22 | $1.84 | $1.64 | $2.02 | $2.04 | |
| Diluted EPS (Cont. Ops) | -$0.22 | $1.81 | $1.62 | $2.01 | $2.02 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $725.4M | $1.1B | $1.4B | $1.7B | $1.8B | |
| EBIT | $270.6M | $638.5M | $933.7M | $1.2B | $1.4B | |
| Revenue (Reported) | $4.5B | $5.4B | $6.2B | $6.9B | $7.3B | |
| Operating Income (Reported) | $374.3M | $681.3M | $965.6M | $1.3B | $1.5B | |
| Operating Income (Adjusted) | $270.6M | $638.5M | $933.7M | $1.2B | $1.4B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.1B | $1.3B | $1.6B | $1.7B | $1.7B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $677.4M | $810.9M | $965.1M | $923.8M | $951.3M | |
| Gross Profit | $452.1M | $526.1M | $664.2M | $746.3M | $765.5M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $252.3M | $265.5M | $311.1M | $336.3M | $350M | |
| Other Inc / (Exp) | $8.2M | -$11.6M | -$9.5M | -$11.1M | -$10.1M | |
| Operating Expenses | $336.5M | $352.9M | $404.8M | $428.8M | $441.1M | |
| Operating Income | $115.6M | $173.2M | $259.4M | $317.5M | $324.4M | |
| Net Interest Expenses | $23.1M | $19M | $38.9M | $36.8M | $61.2M | |
| EBT. Incl. Unusual Items | $100.7M | $142.6M | $211M | $269.6M | $253.1M | |
| Earnings of Discontinued Ops. | -$180.2M | -$1.4M | -- | -- | -- | |
| Income Tax Expense | $10.6M | $32.4M | $48.1M | $54.4M | $58.5M | |
| Net Income to Company | $90.1M | $105.9M | $163.2M | $204.5M | $188.4M | |
| Minority Interest in Earnings | -$300K | -$800K | -$2.1M | -$2.3M | -$1.9M | |
| Net Income to Common Excl Extra Items | -$90.4M | $103.7M | $161.1M | $202.2M | $186.5M | |
| Basic EPS (Cont. Ops) | -$0.22 | $0.25 | $0.40 | $0.50 | $0.46 | |
| Diluted EPS (Cont. Ops) | -$0.22 | $0.25 | $0.39 | $0.50 | $0.46 | |
| Weighted Average Basic Share | $419.2M | $407.6M | $405M | $403.5M | $403.1M | |
| Weighted Average Diluted Share | $425.9M | $413.1M | $409.2M | $407.9M | $406.4M | |
| EBITDA | $229.3M | $270.1M | $363.9M | $423.6M | $434.3M | |
| EBIT | $123.8M | $161.6M | $249.9M | $306.4M | $314.3M | |
| Revenue (Reported) | $1.1B | $1.3B | $1.6B | $1.7B | $1.7B | |
| Operating Income (Reported) | $115.6M | $173.2M | $259.4M | $317.5M | $324.4M | |
| Operating Income (Adjusted) | $123.8M | $161.6M | $249.9M | $306.4M | $314.3M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $1.8B | $2.1B | $1.6B | $1.6B | $1.5B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $861.8M | $948.6M | $1.1B | $1.2B | $1.3B | |
| Inventory | $716.7M | $854.2M | $1B | $1B | $1.1B | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $195.3M | $186.9M | $206.9M | $219.6M | $231.9M | |
| Total Current Assets | $3.9B | $4.1B | $4B | $4.1B | $4.2B | |
| Property Plant And Equipment | $609M | $648.6M | $624.4M | $711.4M | $842.1M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $5.6B | $6B | $6.1B | $6.6B | $8.1B | |
| Other Intangibles | $3.8B | $3.9B | $3.6B | $3.6B | $4.4B | |
| Other Long-Term Assets | $2.2B | $468.7M | $509.1M | $549.4M | $457.2M | |
| Total Assets | $16.1B | $15.2B | $14.8B | $15.6B | $18B | |
| Accounts Payable | $536.4M | $670.5M | $778.7M | $801.2M | $843.6M | |
| Accrued Expenses | $363.6M | $410.4M | $435.4M | $528.8M | $502.5M | |
| Current Portion Of Long-Term Debt | $40.4M | $38.8M | $36.5M | $30.6M | $3.1M | |
| Current Portion Of Capital Lease Obligations | $47.1M | $34.9M | $39.6M | $41.6M | $56.3M | |
| Other Current Liabilities | $212.9M | $17.1M | -- | -- | -- | |
| Total Current Liabilities | $1.5B | $1.5B | $1.7B | $1.8B | $1.8B | |
| Long-Term Debt | $3.9B | $3.4B | $2.7B | $2.7B | $4.8B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $6.9B | $6.1B | $5.5B | $5.7B | $7.8B | |
| Common Stock | $4.2M | $4.3M | $4.3M | $4.3M | $4.3M | |
| Other Common Equity Adj | $14.2M | -$41.6M | -$251.7M | -$227.6M | -$468.5M | |
| Common Equity | $9.1B | $9B | $9.2B | $9.8B | $10.2B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $69.8M | $69.7M | $61.4M | $62.9M | $66.3M | |
| Total Equity | $9.2B | $9.1B | $9.3B | $9.8B | $10.2B | |
| Total Liabilities and Equity | $16.1B | $15.2B | $14.8B | $15.6B | $18B | |
| Cash and Short Terms | $1.8B | $2.1B | $1.6B | $1.6B | $1.5B | |
| Total Debt | $3.9B | $3.4B | $2.8B | $2.7B | $4.8B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $1.6B | $2B | $1.1B | $1.5B | $1.6B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $978.1M | $1B | $1.2B | $1.2B | $1.3B | |
| Inventory | $832.5M | $954.9M | $1.1B | $1.1B | $1.1B | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $199.3M | $217.5M | $186.9M | $257.5M | $257.6M | |
| Total Current Assets | $4.2B | $4.2B | $3.7B | $4B | $4.4B | |
| Property Plant And Equipment | $713.6M | $635.2M | $648.8M | $742.2M | $852.9M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $6.2B | $6B | $6.4B | $6.6B | $8.3B | |
| Other Intangibles | $4.5B | $3.8B | $3.7B | $3.6B | $4.4B | |
| Other Long-Term Assets | $323.9M | $466.5M | $525.3M | $547.8M | $448.9M | |
| Total Assets | $15.9B | $15.1B | $15B | $15.5B | $18.4B | |
| Accounts Payable | $674.2M | $701.4M | $730.9M | $694M | $780.4M | |
| Accrued Expenses | $385.2M | $344.6M | $449.2M | $515.2M | $544.6M | |
| Current Portion Of Long-Term Debt | $40.6M | $40.1M | $33.9M | $31.3M | $1.7M | |
| Current Portion Of Capital Lease Obligations | $47.6M | $35.2M | $41.3M | $42.5M | $62.3M | |
| Other Current Liabilities | $66.7M | $10M | -- | -- | -- | |
| Total Current Liabilities | $1.5B | $1.5B | $1.7B | $1.7B | $1.8B | |
| Long-Term Debt | $3.8B | $3.4B | $2.7B | $2.7B | $4.8B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $6.8B | $6B | $5.6B | $5.6B | $7.8B | |
| Common Stock | $4.2M | $4.3M | $4.3M | $4.3M | $4.3M | |
| Other Common Equity Adj | -$84.4M | -$71.5M | -$226.4M | -$302.6M | -$350.5M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $69M | $71.1M | $64.4M | $64.4M | $68.9M | |
| Total Equity | $9B | $9.1B | $9.4B | $9.9B | $10.6B | |
| Total Liabilities and Equity | $15.9B | $15.1B | $15B | $15.5B | $18.4B | |
| Cash and Short Terms | $1.6B | $2B | $1.1B | $1.5B | $1.6B | |
| Total Debt | $3.9B | $3.4B | $2.7B | $2.7B | $4.8B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$56.8M | $523.4M | $593.3M | $785.1M | $846.3M | |
| Depreciation & Amoritzation | $412.5M | $422.1M | $432.8M | $459.1M | $482M | |
| Stock-Based Compensation | $47.5M | $87.2M | $78.9M | $51.9M | $58.8M | |
| Change in Accounts Receivable | $52.4M | -$62.5M | -$195.2M | -$48.6M | -$45.1M | |
| Change in Inventories | $159M | -$134.4M | -$225.6M | $117.3M | $39.8M | |
| Cash From Operations | $914.3M | $615.5M | $860.3M | $1.4B | $1.4B | |
| Capital Expenditures | $42M | $64.1M | $94.6M | $105.4M | $149.1M | |
| Cash Acquisitions | $9M | -$974.8M | -$246.8M | -$963M | -$3B | |
| Cash From Investing | -$37.9M | $914.3M | -$332.9M | -$1.1B | -$3.1B | |
| Dividends Paid (Ex Special Dividend) | -- | -$8.2M | -$32.4M | -$32.4M | -$32.3M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $2B | -- | -- | $1.5B | $3.3B | |
| Long-Term Debt Repaid | -$1.6B | -$435.7M | -$655.6M | -$1.5B | -$1.2B | |
| Repurchase of Common Stock | -$2.1M | -$736.8M | -$261.1M | -$263M | -$260.7M | |
| Other Financing Activities | -$52.9M | -- | -$24.2M | -$44.8M | -$85.9M | |
| Cash From Financing | $328.7M | -$1.2B | -$954M | -$337.5M | $1.7B | |
| Beginning Cash (CF) | $505.5M | $1.8B | $2.1B | $1.6B | $1.6B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $1.2B | $372.8M | -$426.6M | -$20.6M | -$3.5M | |
| Ending Cash (CF) | $1.8B | $2.1B | $1.6B | $1.6B | $1.5B | |
| Levered Free Cash Flow | $872.3M | $551.4M | $765.7M | $1.3B | $1.2B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $90.1M | $105.9M | $163.2M | $204.5M | $188.4M | |
| Depreciation & Amoritzation | $105.5M | $108.5M | $114M | $117.2M | $120M | |
| Stock-Based Compensation | $21.6M | $19.8M | $12.1M | $14.1M | $14.2M | |
| Change in Accounts Receivable | -$46.8M | -$67.7M | -$83.7M | -$11.5M | $25.3M | |
| Change in Inventories | -$50M | -$99.4M | -$45.3M | -$58.2M | -$54.1M | |
| Cash From Operations | $122.3M | $46M | $170.3M | $161.6M | $256.4M | |
| Capital Expenditures | $14.3M | $17.9M | $22.4M | $62.3M | $33.7M | |
| Cash Acquisitions | -$202.5M | -$30.3M | -$566.4M | -$143.3M | -$163.4M | |
| Cash From Investing | -$208.2M | -$48.2M | -$581.5M | -$205.6M | -$197.1M | |
| Dividends Paid (Ex Special Dividend) | -- | -$8.2M | -$8.1M | -$8.1M | -$8.1M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$9.9M | -$9.6M | -$11M | -$7.1M | -- | |
| Repurchase of Common Stock | -$3M | -$101.1M | -$77M | -$72.9M | -$10M | |
| Other Financing Activities | -- | -$1.8M | -$2.4M | -$2.7M | $2.9M | |
| Cash From Financing | -$7.8M | -$116.1M | -$89.3M | -$79.6M | -$10M | |
| Beginning Cash (CF) | $1.8B | $2.1B | $1.6B | $1.6B | $1.5B | |
| Foreign Exchange Rate Adjustment | -$17.6M | -$1.1M | $6.8M | -$19.6M | $22.3M | |
| Additions / Reductions | -$93.7M | -$118.3M | -$500.5M | -$123.6M | $49.3M | |
| Ending Cash (CF) | $1.6B | $2B | $1.1B | $1.5B | $1.6B | |
| Levered Free Cash Flow | $108M | $28.1M | $147.9M | $99.3M | $222.7M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $71.3M | $539.2M | $650.6M | $826.4M | $830.2M | |
| Depreciation & Amoritzation | $454.8M | $425.1M | $438.3M | $462.3M | $484.8M | |
| Stock-Based Compensation | $65.7M | $85.4M | $71.2M | $53.9M | $58.9M | |
| Change in Accounts Receivable | -$6.5M | -$83.4M | -$211.2M | $23.6M | -$8.3M | |
| Change in Inventories | $128.4M | -$183.8M | -$171.5M | $104.4M | $43.9M | |
| Cash From Operations | $968.2M | $539.2M | $984.6M | $1.4B | $1.5B | |
| Capital Expenditures | $48.7M | $67.7M | $99.1M | $145.3M | $120.5M | |
| Cash Acquisitions | -$234.8M | -$802.6M | -$782.9M | -$539.9M | -$3B | |
| Cash From Investing | -$279.2M | $1.1B | -$866.2M | -$684.6M | -$3.1B | |
| Dividends Paid (Ex Special Dividend) | -- | -$16.4M | -$32.3M | -$32.4M | -$32.3M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$38.4M | -$435.4M | -$657M | -$1.5B | -$1.2B | |
| Repurchase of Common Stock | -$4.3M | -$834.9M | -$237M | -$258.9M | -$197.8M | |
| Other Financing Activities | -- | -- | -$24.8M | -$45.1M | -$80.3M | |
| Cash From Financing | $362.8M | -$1.3B | -$927.2M | -$327.8M | $1.8B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $1.1B | $348.2M | -$808.8M | $356.3M | $169.4M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $919.5M | $471.5M | $885.5M | $1.2B | $1.4B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $90.1M | $105.9M | $163.2M | $204.5M | $188.4M | |
| Depreciation & Amoritzation | $105.5M | $108.5M | $114M | $117.2M | $120M | |
| Stock-Based Compensation | $21.6M | $19.8M | $12.1M | $14.1M | $14.2M | |
| Change in Accounts Receivable | -$46.8M | -$67.7M | -$83.7M | -$11.5M | $25.3M | |
| Change in Inventories | -$50M | -$99.4M | -$45.3M | -$58.2M | -$54.1M | |
| Cash From Operations | $122.3M | $46M | $170.3M | $161.6M | $256.4M | |
| Capital Expenditures | $14.3M | $17.9M | $22.4M | $62.3M | $33.7M | |
| Cash Acquisitions | -$202.5M | -$30.3M | -$566.4M | -$143.3M | -$163.4M | |
| Cash From Investing | -$208.2M | -$48.2M | -$581.5M | -$205.6M | -$197.1M | |
| Dividends Paid (Ex Special Dividend) | -- | -$8.2M | -$8.1M | -$8.1M | -$8.1M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$9.9M | -$9.6M | -$11M | -$7.1M | -- | |
| Repurchase of Common Stock | -$3M | -$101.1M | -$77M | -$72.9M | -$10M | |
| Other Financing Activities | -- | -$1.8M | -$2.4M | -$2.7M | $2.9M | |
| Cash From Financing | -$7.8M | -$116.1M | -$89.3M | -$79.6M | -$10M | |
| Beginning Cash (CF) | $1.8B | $2.1B | $1.6B | $1.6B | $1.5B | |
| Foreign Exchange Rate Adjustment | -$17.6M | -$1.1M | $6.8M | -$19.6M | $22.3M | |
| Additions / Reductions | -$93.7M | -$118.3M | -$500.5M | -$123.6M | $49.3M | |
| Ending Cash (CF) | $1.6B | $2B | $1.1B | $1.5B | $1.6B | |
| Levered Free Cash Flow | $108M | $28.1M | $147.9M | $99.3M | $222.7M | |
Get IR Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
IR
Sector
P/E ratio
38.09x
17.22x
PEG ratio
76.57x
0.27x
P/B ratio
2.96x
1.65x
Price / LTM sales
4.30x
0.89x
Growth Metrics
IR
Sector
Revenue growth
2.8%
2.39%
Earnings growth
-8%
4.52%
Revenue (5-year growth)
29.1%
4.4%
Earnings forecast
$0.74
$0.29
Profitability
IR
Sector
Profitability FY 2024
$3.2B
$406.4M
Return on invested capital
5.65%
5.65%
Return on assets
4.68%
3.52%
Return on equity
8.06%
8.69%
Earnings Date
Last Earnings Date
May
1
Next Earnings Date
Jul
31
Estimated Next Earnings Date
Jul
31
Balance Sheet
IR
Sector
Total cash
$1.6B
$165.5M
Short term investments
--
$37.1M
Total assets
$18B
$1.8B
Long term debt
$4.8B
$283M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire The Best Stock to Buy in a Bad Market?
Berkshire Hathaway (NYSE:BRK.A, BRK.B) has historically been one of the…
Is Shopify Stock Still a Buy in 2025 or Has Growth Peaked?
The big picture trends in e‑commerce sales are clearly in…
Stock Ideas
Buy
71
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
63
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Buy
60
RGC alert for May 6
Regencell Bioscience Holdings [RGC] is up 73.72% over the past day.
Buy
63
SKX alert for May 6
Skechers USA [SKX] is down 0.07% over the past day.
Sell
20
PTCT alert for May 6
PTC Therapeutics [PTCT] is down 11% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
